Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00850577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blinded Phase II Study of Carboplatin/Paclitaxel/CT-322 Versus Carboplatin/Paclitaxel/Bevacizumab as First-Line Treatment for Recurrent or Advanced Non-Small Cell Lung Cancer With Non-Squamous Histology
Study identification
- NCT ID
- NCT00850577
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
- Bevacizumab placebo (ie saline solution) Drug
- CT-322 Drug
- Carboplatin Drug
- Paclitaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2009
- Primary completion
- Jul 31, 2013
- Completion
- Jul 31, 2013
- Last update posted
- Oct 11, 2015
2009 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acrc/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Cancer Institute Of Florida | Orlando | Florida | 32804 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33401 | — |
| Clintell, Inc. | Skokie | Illinois | 60077 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| Annapolis Oncology Center | Annapolis | Maryland | 21401 | — |
| Meritus Center For Clinical Research | Hagerstown | Maryland | 21740 | — |
| North Mississippi Hematology And Oncology Associates, Ltd | Tupelo | Mississippi | 38801 | — |
| Piedmont Hematology Oncology Associates, Pllc | Winston-Salem | North Carolina | 27103 | — |
| North Canton Medical Clinic Center | Canton | Ohio | 44710 | — |
| Kaiser Permanente Oncology/Hematology | Portland | Oregon | 97227 | — |
| Guthrie Clinic, Ltd | Sayre | Pennsylvania | 18840 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Charleston Hematology Oncology Associates, Pa | Charleston | South Carolina | 29414 | — |
| Cancer Center At Cookeville Regional Medical Center | Cookeville | Tennessee | 38501 | — |
| University Of Tennessee Cancer Institute | Memphis | Tennessee | 38104 | — |
| Blue Ridge Cancer Care | Christiansburg | Virginia | 24073 | — |
| Providence Western Washington Oncology | Lacey | Washington | 98503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00850577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2015 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00850577 live on ClinicalTrials.gov.